Symbol
| BMP7
| contributors: mct/npt - updated : 21-03-2016
|
HGNC name
| bone morphogenetic protein 7
|
HGNC id
| 1074
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in breast cancer | tumoral
|  
| amplification
|  
|  
|
in breast cancer | tumoral
|  
|  
| --over
|  
|
in myelofibrosis | tumoral
|  
|  
| --low
|  
|
in primary breast cancer is significantly associated with the formation of clinically overt bone metastases | |
Susceptibility
|
to hypospadias |
Variant & Polymorphism
other
| polymorphism increasing the risk of hypospadias |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
obesity | | | |
. potential new therapeutic approach for the treatment of obesity (treatment with BMP7 or its molecular mimetic may activate brown fat differentiation, leading to an increase in energy expenditure, and thereby providing a new way to combat obesity | cancer | reproductive | breast | |
. may represent a novel therapeutic molecule for repression of local and bone metastatic growth of breast cancer | miscelleaneous | urinary | | |
possible treatment for reversing end-stage renal disease |
| | | |
| Bmp7-deficient mice exhibit substantially diminished Langerhans cell (LC) numbers, with the remaining cells appearing less dendritic |